Influenza (pandemic)

VaxCorps coordinates global vaccine solutions network

PMG Research, Benchmark Research and Miami Research Associates have joined forces to create VaxCorps, a vaccine site network to advance and develop vaccine solutions.
The goal of VaxCorps is to further innovative solutions for the vaccine industry’s practices, reproduction capabilities and standardization through the industry’s large-scale trials. The network will contain experienced clinical research centers located around the world that are dedicated to conducting vaccine trials among diverse populations.

Annual New Technologies, New Vaccines conference to begin Sunday

World health industry leaders will meet for the 10th Annual New Technologies, New Vaccines conference Sunday through Wednesday in Wilmington, Delaware.
Over 100 business owners, representatives of regulatory agencies and scientists traveled from across the globe to attend the conference. The leaders will exchange their latest discoveries and advancements as they battle against deadly diseases and potential future pandemics like HIV, Ebola and influenza strains.

Discussion topics from Pandemic Influenza, 2nd Edition

Pandemic influenza is a re-emerging disease with serious public health consequences. The H1N1 pandemic in 2009-10 and the continuing threat to humans from avian influenza H5N1 and H5N8 have underlined this threat.
Particularly in an increasingly globalised society, it is essential that we have preparedness plans in please at a local, national and international level.

MediVector finishes enrolling subjects in two Phase 3 favipiravir studies

MediVector, Inc. recently announced that it has finished enrolling subjects in its two FAVOR favipiravir Phase 3 studies for influenza treatments.
Favipiravir, also called T-705, is an orally administered antiviral candidate with a broad-spectrum of treatments. The treatment inhibits RNA messengers and genomes from producing the proteins that are essential to forming new viruses.

Investigators advance a new therapy to use against pneumonia, influenza

Scientists at the Nanyang Technological University in Singapore say they've completed a successful mouse study of a new antibody designed to spur the recovery of patients suffering from pneumonia and influenza. And they're now preparing for human studies.
NTU Singapore's Associate Professor Andrew Tan led an interdisciplinary team of scientists to test the antibody, which blocks the protein ANGPTL4, found in high concentrations in tissue from flu and pneumonia patients.

Pandemic immune response hints at potential universal flu vaccine

The search for a universal flu vaccine has focused on the stem of the lollipop-shaped hemagglutinin of the influenza virus. While the composition of the head changes, the stem is fairly constant from strain to strain. New data shows the body takes advantage of this fact too.

Le vaccin contre la grippe aurait des qualités insoupçonnées

Le vaccin contre la grippe, différent chaque année pour suivre la constante évolution du virus, ferait même plus. C'est ce qu'avance une équipe de l'hôpital pour enfants de St Jude à Memphis dans une étude dont les résultats ont été publiés dans la revue web de l'American Society for Microbiology. Des chercheurs qui affirment que ce vaccin saisonnier protégerait également contre d'autres souches de grippe non ciblées par les créateurs du vaccin.

STC to work with Alberta Health to control vaccine inventory

Scientific Technologies Corporation (STC) was recently awarded a contract with Alberta Health to help improve the management process and distribution of vaccine supply.

Early backer of Uber funds smartphone-based device for at-home diagnosis of flu

Shervin Pishevar, one of the earlier backers of new-age taxi service Uber, is throwing his support behind San Diego startup Cue, which is developing a home-enabled diagnostic for testing for testosterone, fertility, inflammation, vitamin D and influenza.

Vaccine ignorance -- deadly and contagious

In the absence of credible, strong political leadership, paranoia about disease can go viral. We've seen this happen around the world with a wide range of illnesses, from swine flu to SARS to Ebola.
And even after threats are addressed, a new form of conspiratorial thinking often emerges, this time focused not on the microbes but on the tools used to keep the germs at bay — especially vaccines.